How should I manage a 67-year-old female long-term care patient with normocytic anemia (hemoglobin 7.8 g/dL, hematocrit 24 %, mean corpuscular volume 93 fL, red cell distribution width 17 %), normal renal function (estimated glomerular filtration rate 89 mL/min/1.73 m²), sub‑therapeutic international normalized ratio 1.21, mild hyponatremia (serum sodium 135 mmol/L) and low serum calcium (8.1 mg/dL)?

Management of Normocytic Anemia in a 67-Year-Old Long-Term Care Patient

This patient requires immediate investigation for iron deficiency and gastrointestinal blood loss, followed by iron supplementation and consideration of blood transfusion given the severe symptomatic anemia (hemoglobin 7.8 g/dL).

Immediate Diagnostic Workup

Your patient presents with severe normocytic anemia (MCV 93.3 fL, hemoglobin 7.8 g/dL) with an elevated RDW (17%), which strongly suggests iron deficiency despite the normocytic indices 1, 2. The elevated RDW indicates a mixed population of red cells and is an early marker of iron deficiency before microcytosis develops 1.

Essential Laboratory Tests to Order Now:

• Serum ferritin and transferrin saturation (TSAT) - These are the minimum requirements to assess iron status 2
• Reticulocyte count - To determine if bone marrow is responding appropriately 3, 4
• Vitamin B12 and folate levels - Common deficiencies in elderly long-term care patients 2, 5
• Inflammatory markers (CRP) - To distinguish iron deficiency anemia from anemia of chronic disease 1

Critical interpretation for elderly patients: In the presence of inflammation, ferritin >100 μg/L with TSAT <20% indicates anemia of chronic disease; ferritin 30-100 μg/L suggests combined iron deficiency and chronic disease 1. For elderly patients without CKD, absolute iron deficiency is defined as TSAT <15% and ferritin <30 ng/mL 3.

Gastrointestinal Investigation

Given the severity of anemia in a 67-year-old, bidirectional endoscopy (upper and lower GI evaluation) is strongly recommended 2. The British Society of Gastroenterology guidelines specifically emphasize that elderly patients have higher rates of malignancy and dual pathology, strengthening the case for complete GI evaluation 2.

However, weigh risks versus benefits carefully in this long-term care patient - consider frailty status, comorbidities, and life expectancy before proceeding with invasive testing 2. CT colonography may be a reasonable alternative if colonoscopy poses excessive risk 2.

Treatment Algorithm

1. Transfusion Decision (Immediate)

With hemoglobin 7.8 g/dL, assess for symptoms of severe anemia:

• Extreme weakness or fatigue limiting activities
• Chest pain, dyspnea at rest, or cardiac symptoms
• Altered mental status or dizziness

If symptomatic: Transfuse 1-2 units of packed red blood cells 6. The KDIGO guidelines support transfusion when benefits outweigh risks in chronic anemia, particularly when symptoms are present 6.

If asymptomatic or mildly symptomatic: Avoid transfusion and proceed directly to iron therapy 6. The goal is to minimize transfusion-related risks including allosensitization and volume overload 6.

2. Iron Replacement (Start Immediately)

First-line: Oral iron supplementation - Ferrous sulfate 325 mg once daily or ferrous fumarate 325 mg once daily 2. Oral iron remains standard first-line treatment in elderly patients 2.

Switch to intravenous iron if:

• Gastrointestinal intolerance to oral iron
• Inadequate response after 4 weeks (hemoglobin increase <2 g/dL) 1
• Concurrent inflammatory conditions limiting oral absorption
• Patient preference for convenience 2

Expected response: Hemoglobin should increase by at least 2 g/dL within 4 weeks of treatment 1. Monitor hemoglobin every 2-4 weeks initially.

3. Address Electrolyte Abnormalities

Mild hyponatremia (135 mmol/L): Likely dilutional or related to chronic disease. Monitor but does not require immediate intervention unless symptomatic.

Low calcium (8.1 mg/dL): Check albumin level to calculate corrected calcium. If truly low, supplement with calcium carbonate 500-1000 mg daily with vitamin D. Consider checking PTH and vitamin D levels given long-term care setting.

4. Anticoagulation Management

INR 1.21 is mildly elevated but not in therapeutic range. Review medication list for:

• Warfarin or other anticoagulants (may contribute to occult bleeding)
• Antiplatelet agents (aspirin, clopidogrel)
• NSAIDs

If patient is on anticoagulation for atrial fibrillation or VTE prophylaxis, this subtherapeutic INR requires adjustment. However, consider holding anticoagulation temporarily if active GI bleeding is suspected until source is identified and controlled.

Special Considerations for Long-Term Care Elderly Patients

Multifactorial anemia is the rule, not the exception in this population 5, 7, 8. Approximately 45% have nutritional deficiencies, 40% have anemia of chronic inflammation, and many have combined etiologies 7.

Common pitfalls to avoid:

• Assuming anemia is "normal aging" - it is not and requires investigation 7, 8
• Missing combined deficiencies (iron + B12 + folate) which can mask each other 1, 2
• Over-relying on MCV alone - elevated RDW is more sensitive for early iron deficiency 1
• Undertreating due to age - elderly patients benefit significantly from anemia correction 5

Monitoring Plan

• Hemoglobin: Every 2-4 weeks until stable, then every 3 months 6
• Iron studies: Repeat in 4-8 weeks after starting supplementation
• Renal function: Already adequate (eGFR 89), monitor every 6-12 months
• Symptoms: Assess functional status, cognition, and mobility regularly - anemia significantly impacts these domains in elderly 5, 7

Target hemoglobin: Aim for 11-12 g/dL in elderly patients. Avoid aggressive correction above 13 g/dL, which may increase cardiovascular risks without additional benefit 6.